Meet Areej El-Jawahri, M.D., Director of the Bone Marrow Transplant Survivorship Program at Massachusetts General Cancer Center. Massachusetts General Cancer Center is the 2020 Incyte Ingenuity Award recipient. Dr. El-Jawahri explains how devastating graft-versus-host disease (#GVHD) can be for patients, and how the Incyte Ingenuity Award program aims to support people living with GVHD, as well as their caregivers and physicians. The Incyte Ingenuity Award program encourages innovative and novel solutions to address the specific needs of the GVHD community. GVHD is a life-threatening condition that occurs when donor immune cells attack the recipient's organs and tissues after an allogeneic stem cell transplantation. There are two major forms of GVHD, acute and chronic, that can affect multiple organ systems, including the skin, digestive tract, and the liver. To learn more about GVHD and the Incyte Ingenuity Award Program, please visit https://www.incyteingenuityawards.com/. Find Incyte online & on social media: Twitter: https://twitter.com/incyte LinkedIn: https://www.linkedin.com/company/incyte/ Facebook: https://www.facebook.com/incyte/ Website: https://www.incyte.com/ © 2021, Incyte Corporation. MAT-INC-01323 05/21